Fluconazole
Pre-clinicalCompleted 1 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Fungal Infection by Site
Conditions
Fungal Infection by Site
Trial Timeline
Jul 1, 2008 → Dec 1, 2009
NCT ID
NCT00721487About Fluconazole
Fluconazole is a pre-clinical stage product being developed by Astellas Pharma for Fungal Infection by Site. The current trial status is completed. This product is registered under clinical trial identifier NCT00721487. Target conditions include Fungal Infection by Site.
What happened to similar drugs?
9 of 20 similar drugs in Fungal Infection by Site were approved
Approved (9) Terminated (3) Active (10)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00721487 | Pre-clinical | Completed |
Competing Products
20 competing products in Fungal Infection by Site